Ramm Pharma Corp (RAMM)

CSE

Currency in CAD

0.01

0.00(0.00%)

Delayed Data·29/04

Fair Value

Unlock Value

Day's Range

0.01

52 wk Range

0.01

0.25

RAMM Income Statement

Assess the Ramm Pharma income statement, providing a detailed view of the company’s financial performance across activities. This statement outlines key financial figures such as revenue, expenses, operating income, and net income. Assess the RAMM net worth.

Period Ending:

2018

31/10

2019

31/10

2020

31/10

2021

31/10

2022

31/10

2023

31/10

2024

31/10

2025

31/10

Total Revenues

aa.aa

5.07

4.34

3.36

Total Revenues Growth

aa.aa

+29.96%

-14.28%

-22.6%

Cost Of Revenues

aa.aa

4.64

2.57

2.51

Gross Profit

aa.aa

0.42

1.78

0.85

Gross Profit Growth

aa.aa

-12.79%

+320.47%

-52.25%

Gross Profit Margin %

aa.aa

8.34%

40.92%

25.25%

Other Operating Expenses, Total

aa.aa

7.51

10.72

5.38

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-10.83%	+42.7%	-49.79%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	7.36	10.59	5.3
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	0.15	0.12	0.08

Operating Income

aa.aa

-7.09

-8.94

-4.53

Operating Income Growth

aa.aa

+10.72%

-26.14%

+49.31%

EBIT Margin %

aa.aa

-139.9%

-205.86%

-134.83%

Net Interest Expenses

aa.aa

0.14

-0.01

-0.24

Net Interest Expenses Growth

aa.aa

-5.35%

-107.47%

-2,138.52%

Interest Expense, Total

aa.aa

-0.05

-0.04

-0.24

Interest And Investment Income

aa.aa

0.2

0.03

0.01

Other Non Operating Expenses, Total

aa.aa

0.31

0.01

-0.13

EBT, Excl. Unusual Items

aa.aa

-6.64

-8.93

-4.89

Gain (Loss) On Sale Of Assets

aa.aa

0.77

Other Unusual Items, Total

aa.aa

-1.07

-7.56

-4.77

EBT, Incl. Unusual Items

aa.aa

-7.71

-16.49

-8.89

EBT, Incl. Unusual Items Growth

aa.aa

+63.2%

-113.9%

+46.07%

EBT, Incl. Unusual Items Margin

aa.aa

-152.24%

-379.87%

-264.68%

Income Tax Expense

aa.aa

0.01

0.02

Net Income to Company

aa.aa

-7.72

-16.5

-8.91

Minority Interest

aa.aa

Net Income

aa.aa

-7.72

-16.5

-8.91

Net Income Growth

aa.aa

+63.16%

-113.73%

+46.01%

Net Income Margin %

aa.aa

-152.43%

-380.06%

-265.13%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

-7.72

-16.5

-8.91

Basic EPS - Continuing Operations

aa.aa

-0.06

-0.14

-0.07

Basic EPS - Continuing Operations Growth

aa.aa

+62.63%

-116.68%

+46.01%

Diluted EPS - Continuing Operations

aa.aa

-0.06

-0.14

-0.07

Diluted EPS - Continuing Operations Growth

aa.aa

+62.63%

-116.68%

+46.01%

Basic Weighted Average Shares Outstanding

aa.aa

121.04

119.39

Diluted Weighted Average Shares Outstanding

aa.aa

121.04

119.39

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

EBITDA

aa.aa

-6.03

-7.97

-3.93

EBITDA Growth

aa.aa

+13.93%

-32.18%

+50.68%

EBITDA Margin %

aa.aa

-119%

-183.49%

-116.92%

EBIT

aa.aa

-7.09

-8.94

-4.53

* In Millions of CAD (except for per share items)

FAQ

What was Ramm Pharma’s revenue at year end?

At the end of the last reported fiscal year, Ramm Pharma (RAMM) recorded total revenue of 3.36 million CAD.

How much revenue did Ramm Pharma report in the most recent quarter?

In its most recent quarterly earnings report, Ramm Pharma posted revenue of 0.21 million CAD.

What was Ramm Pharma’s net income for the year?

For the full year, Ramm Pharma reported net income of -8.91 million CAD.

How much net income did Ramm Pharma post in the last quarter?

In the most recent quarter, Ramm Pharma (RAMM) posted net income of -0.76 million CAD.

What was Ramm Pharma’s gross profit for the year?

Gross profit for the year was reported at 0.85 million CAD.

How much gross profit did Ramm Pharma generate last quarter?

Ramm Pharma recorded gross profit of 0.14 million CAD in its latest quarterly report.

What was Ramm Pharma’s annual operating income?

For the full year, Ramm Pharma (RAMM) reported operating income of -4.53 million CAD.

What was Ramm Pharma’s operating income last quarter?

Quarterly operating income was -0.94 million CAD.

What was Ramm Pharma’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at -0.83 million CAD.

What was the quarter-over-quarter change in EBITDA for Ramm Pharma?

EBITDA changed by 41.23% million CAD compared to the last quarter.

What is Ramm Pharma’s most recent gross profit margin?

The latest reported gross profit margin for Ramm Pharma (RAMM) is 63.93% million CAD.

What is Ramm Pharma’s most recent net income margin?

Net income margin based on recent financials is -356.57% million CAD.

What is Ramm Pharma’s most recent EBIT margin?

Ramm Pharma reported an EBIT margin of -440.38% million CAD based on current figures.

How did Ramm Pharma’s revenue change compared to the previous quarter?

Revenue changed by -64.88% million CAD compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Ramm Pharma?

In the latest quarter, gross profit changed by -71.25% million CAD from the previous quarter.

S&P/TSX

33,846.99

-44.19

-0.13%

S&P/TSX 60

1,974.09

-3.71

-0.19%

US 30

49,268.00

-231.0

-0.47%

US 500

7,225.50

-4.6

-0.06%

S&P 500 VIX

17.38

+0.39

+2.30%

DAX

24,145.00

-147.38

-0.61%

Dollar Index

98.172

+0.167

+0.17%

Market Movers

Name	Last	Chg. %	Vol.
Bank of Montreal	206.60	-0.39%	3.02M
Canadian Natural	63.77	-0.17%	766.86K
Bank of Nova Scotia	105.30	-0.71%	434.50K
Toronto Dominion Bank	146.26	+0.29%	387.30K
TC Energy	89.72	-1.00%	294.41K
RBC	243.15	-0.43%	265.66K
Fairfax Financial	2,247.93	+3.58%	12.88K

Name	Last	Chg. %	Vol.
PeakBirch Logic	0.030	0.00%	0.00
Vertiqal Studios	0.01	0.00%	0.00
Vertiqal Studios	0.01	0.00%	607.10K
Irwin Naturals	0.30	0.00%	0.00
Taurus Gold	0.07	0.00%	0.00
Green Scientific Labs Holdings	0.06	0.00%	0.00
ePlay Digital	0.010	0.00%	0.00

Name	Last	Chg. %
Nirvana Life Sciences	0.01	0.00%
Resource Centrix Holdings	1.50	0.00%
Noveris Health Sciences	0.80	0.00%
Noveris Health Sciences	0.800	0.00%
Patriot Gold	0.07	0.00%
Armada Mercantile Ltd	0.135	0.00%
Molecule Holdings	0.005	0.00%

Trending Stocks

Name	Last	Chg. %	Vol.
TELUS	17.04	-0.18%	615.15K
Canadian Natural	63.77	-0.17%	766.86K
Keel Infra	4.41	+5.50%	833.74K
Celestica Inc.	566.53	-0.52%	43.47K
Cenovus Energy Inc	39.90	+0.20%	1.06M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaa Aaaaaaaa Aa	91.35	+67.25%	152.78
A Aaaa A	3.16	+59.88%	5.05
Aaaaaaaaaaaaaa	10.250	+53.95%	15.780
Aaaaaaaaa	5.38	+52.64%	8.21
Aaa Aaa	7.71	+52.11%	11.73
Aaaaaa	10.73	+41.41%	15.17
Aaaa A A Aaa	11.10	+40.66%	15.61

Name	Last	Upside	Fair Value
Aaa Aaaaaaaa Aa	91.35	+67.25%	152.78
A Aaaa A	3.16	+59.88%	5.05
Aaaaaaaaaaaaaa	10.250	+53.95%	15.780
Aaaaaaaaa	5.38	+52.64%	8.21
Aaa Aaa	7.71	+52.11%	11.73
Aaaaaa	10.73	+41.41%	15.17
Aaaa A A Aaa	11.10	+40.66%	15.61

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Ramm Pharma Corp (RAMM)

RAMM Income Statement

FAQ

What was Ramm Pharma’s revenue at year end?

How much revenue did Ramm Pharma report in the most recent quarter?

What was Ramm Pharma’s net income for the year?

How much net income did Ramm Pharma post in the last quarter?

What was Ramm Pharma’s gross profit for the year?

How much gross profit did Ramm Pharma generate last quarter?

What was Ramm Pharma’s annual operating income?

What was Ramm Pharma’s operating income last quarter?

What was Ramm Pharma’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for Ramm Pharma?

What is Ramm Pharma’s most recent gross profit margin?

What is Ramm Pharma’s most recent net income margin?

What is Ramm Pharma’s most recent EBIT margin?

How did Ramm Pharma’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for Ramm Pharma?

Trending Stocks